Lucas Svetlana
- SEC CIK
- 0001781292
Latest role at each company
- JSPR Jasper Therapeutics, Inc.Directoras of Aug 4, 2026
- SCTX Scribe Therapeutics, Inc.Chief Business Officeras of Jul 27, 2026
- ATYR aTYR PHARMA INCDirectoras of May 13, 2026
Trades
Every Form 4 that lists Lucas Svetlana as a reporting owner, including filings made jointly with others. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Company | Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| SCTXScribe Therapeutics, Inc. | Jul 27, 20269:42 PM ET | Jul 23, 2026 | Lucas SvetlanaChief Business Officer | PPurchaseCommon Stock | +3K | $15.00 | +$45K | 3K | New position | SEC |
| JSPRJasper Therapeutics, Inc. | Sep 24, 2025 | Sep 22, 2025 | Lucas SvetlanaDirector | PPurchaseVoting Common Stock | +20K | $2.43 | +$48.6K | 20K | New position | SEC |
| JSPRJasper Therapeutics, Inc. | Sep 24, 2025 | Sep 22, 2025 | Lucas SvetlanaDirector | PPurchaseVoting Common Stock · Derivative | +20K | – | – | 20K | – | SEC |